SE7413710L - - Google Patents

Info

Publication number
SE7413710L
SE7413710L SE7413710A SE7413710A SE7413710L SE 7413710 L SE7413710 L SE 7413710L SE 7413710 A SE7413710 A SE 7413710A SE 7413710 A SE7413710 A SE 7413710A SE 7413710 L SE7413710 L SE 7413710L
Authority
SE
Sweden
Prior art keywords
glycyl
radical
optionally substituted
amino acid
benzene ring
Prior art date
Application number
SE7413710A
Other languages
English (en)
Inventor
C R Beddell
L A Lowe
S Wilkinson
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB4391774A external-priority patent/GB1501855A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE7413710L publication Critical patent/SE7413710L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7413710A 1973-11-01 1974-10-31 SE7413710L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5081173 1973-11-01
GB4391774A GB1501855A (en) 1974-10-10 1974-10-10 Nona-and decapeptide amides

Publications (1)

Publication Number Publication Date
SE7413710L true SE7413710L (fi) 1975-05-02

Family

ID=26265264

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7413710A SE7413710L (fi) 1973-11-01 1974-10-31

Country Status (10)

Country Link
US (1) US3992365A (fi)
JP (1) JPS5088069A (fi)
AU (1) AU497418B2 (fi)
CA (1) CA1030526A (fi)
DE (1) DE2451841A1 (fi)
DK (1) DK568274A (fi)
FR (1) FR2249677B1 (fi)
IE (1) IE40257B1 (fi)
NL (1) NL7414241A (fi)
SE (1) SE7413710L (fi)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4083967A (en) * 1973-11-01 1978-04-11 Burroughs Wellcome Co. Nona- and decapeptides
US4089946A (en) * 1976-06-07 1978-05-16 American Home Products Corporation Claudogenic-interceptive nonapeptides
US4256737A (en) * 1979-06-11 1981-03-17 Syntex (U.S.A.) Inc. Long acting depot injectable formulations for LH-RH analogues
DE3020941A1 (de) * 1980-06-03 1981-12-17 Hoechst Ag, 6000 Frankfurt Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung
US4318905A (en) * 1980-06-23 1982-03-09 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide agonists of luteinizing hormone releasing hormone containing heterocyclic amino acid residues
US4443368A (en) * 1982-11-01 1984-04-17 The Salk Institute For Biological Studies Peptides affecting gonadal function
HU189394B (en) * 1983-12-23 1986-06-30 Koezponti Valto- Es Hitelbank Rt Innovacios Alap,Hu Method for producing spermatozoa suitable for fertilization from mature fishes
US4705778A (en) * 1985-10-22 1987-11-10 Sri International Orally active LHRH analogs
HU194280B (en) * 1985-10-22 1988-01-28 Richter Gedeon Vegyeszet Process for producing new gonadoliberin analogues of high effectivity and pharmaceutical compositions containing them
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US20060025328A1 (en) * 1997-05-28 2006-02-02 Burns Patrick J Compositions suitable for controlled release of the hormone GnRH and its analogs
US6051558A (en) * 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
US20040265285A1 (en) * 1999-04-15 2004-12-30 Monash University Normalization of defective T cell responsiveness through manipulation of thymic regeneration
US20040259803A1 (en) * 1999-04-15 2004-12-23 Monash University Disease prevention by reactivation of the thymus
US20040241842A1 (en) * 1999-04-15 2004-12-02 Monash University Stimulation of thymus for vaccination development
US20070274946A1 (en) * 1999-04-15 2007-11-29 Norwood Immunoloty, Ltd. Tolerance to Graft Prior to Thymic Reactivation
US20040258672A1 (en) * 1999-04-15 2004-12-23 Monash University Graft acceptance through manipulation of thymic regeneration
US20050020524A1 (en) * 1999-04-15 2005-01-27 Monash University Hematopoietic stem cell gene therapy
AUPR074500A0 (en) * 2000-10-13 2000-11-09 Monash University Treatment of t cell disorders
US20060088512A1 (en) * 2001-10-15 2006-04-27 Monash University Treatment of T cell disorders
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
AU2003299659A1 (en) * 2002-12-13 2004-07-09 Durect Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
US20080279812A1 (en) * 2003-12-05 2008-11-13 Norwood Immunology, Ltd. Disease Prevention and Vaccination Prior to Thymic Reactivation
JP5285275B2 (ja) 2004-09-17 2013-09-11 デュレクト コーポレーション 制御されたデリバリーシステム
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
AU2007325918B2 (en) 2006-11-03 2013-10-17 Durect Corporation Transdermal delivery systems comprising bupivacaine
JP2011506318A (ja) 2007-12-06 2011-03-03 デュレクト コーポレーション 経口医薬製剤
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1009230A (en) * 1972-09-26 1977-04-26 Daiichi Seiyaku Co. Peptides effecting to the release of sex hormones and a method for preparing the same
US3853834A (en) * 1972-10-19 1974-12-10 Lilly Co Eli 4-alanine lh-rh analog

Also Published As

Publication number Publication date
NL7414241A (nl) 1975-05-06
IE40257B1 (en) 1979-04-25
JPS5088069A (fi) 1975-07-15
FR2249677B1 (fi) 1978-07-28
DE2451841A1 (de) 1975-05-07
FR2249677A1 (fi) 1975-05-30
DK568274A (fi) 1975-06-23
CA1030526A (en) 1978-05-02
AU7493074A (en) 1976-05-06
US3992365A (en) 1976-11-16
AU497418B2 (en) 1978-12-14
IE40257L (en) 1975-05-01

Similar Documents

Publication Publication Date Title
SE7413710L (fi)
ES8203385A1 (es) Procedimiento de obtencion de nuevos derivados de la vin- blastina
CA2024651A1 (en) High-absorbable transvaginal preparation containing biologically active polypeptide
IT1196916B (it) Peptidi biologicamente attivi
DK624884D0 (da) Peptider
NO871574L (no) Fremgangsmaate for fremstilling av terapeutisk aktive peptider.
NL7700785A (nl) Biologisch actieve peptiden ter vervanging van morfine.
NL930103I2 (nl) Nonapeptide- en decapeptidederivaten van tot afgifte van luteiniserend hormoon aanzettend hormoon, bereiding daarvan en farmaceutische preparaten, di e deze bevatten.
ATE63750T1 (de) Peptid, dessen herstellung und benutzung.
ATE10364T1 (de) Retro-inverso analoga von c-terminalen pentaund hexapeptiden der verbindung p.
ZA896245B (en) A new antibiotic,mersacidin,a process for the preparation thereof and the use thereof as a pharmaceutical
GB1557076A (en) Psychopharmacologically active peptides and peptide derivatives and the use thereof
ATE90359T1 (de) Peptide.
NL7607683A (nl) Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
GB1109086A (en) Polypeptides
JPS51118739A (en) Preparation of ll33*3*4 dihydroxyyphenyl**22methyll alanine peptide
ATE173022T1 (de) Produktion von peptid-amiden
AU503998B2 (en) Peptides and peptide synthesis
AU3784072A (en) A process for the preparation of new complexes of biologically active peptides, polypetrides, proteins or derivatives or salts thereof having prolonged and/or increased activity
GB1329869A (en) Tetracycline derivatives
GB8718325D0 (en) Peptides & peptid derivatives
DE3869939D1 (de) Biologisch wirksame peptide.
AU502568B2 (en) Preparation ofd-carbamoyl amino acids aid corresponding d-amino acids
ATE59393T1 (de) Peptide.
ES2063332T3 (es) Solucion de infusion nefroprotectora.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7413710-0